Top of the morning to you. Another balmy day here on the Pharmalot corporate campus, where an usual quiet has set in now that the short people are busy with their summer activities. We are keeping busy, of course, sifting through documents. And you? Projects and meetings beckon, no doubt. To cope, please join us for a cup of stimulation and a peek at a few interesting items. Have a nice day, everyone...
Novartis Can't Force Alcon Merger (PharmaTimes)
Teva Gets FDA OK For Generic Effexor XR (Reuters)
UK's NICE Reverses Decision On Rheumatoid Arthritis Meds (PharmaTimes)
Speeding Clinical Trial Recruitment With E-records (Outsourcing Pharm)
Abbott Puts Solvay Flu Biz Up For Sale (The Wall Street Journal)
Taro Pharma Gets NASDAQ Reprieve (Ha'aretz)